Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00091988 · ClinicalTrials.gov registry record · NA
Program to Reduce Incontinence by Diet and Exercise
A NA study, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- NA
- Development phase
- 338
- Enrollment target
NCT00091988: Completed NA study, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
NCT00091988 is a NA study that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 338 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00091988, a NA study, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- NA
- Development phase
- 338 participants
- Enrollment target
Study Summary
PRIDE will evaluate the impact of weight loss on urinary incontinence in a randomized, controlled trial.
Primary Outcome
Change in the number of incontinence episodes reported in a 7-day voiding diary from baseline to 6 months
Interventions
- BEHAVIORAL Lifestyle & Behavioral Change Program
- BEHAVIORAL Structured Education Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 338 participants |
| Start Date | 2004-07 |
| Est. Completion | 2007-11 |
| Phase | NA |
What the finished NCT00091988 record still lists
NCT00091988 is an interventional study that assigns participants to a tested intervention. The registered 338 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower).
The record links to 0 conditions, and to 2 interventions - of which Lifestyle & Behavioral Change Program is the first listed.
NCT00091988 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00091988 about?
NCT00091988 is a clinical study titled "Program to Reduce Incontinence by Diet and Exercise". PRIDE will evaluate the impact of weight loss on urinary incontinence in a randomized, controlled trial.
What is the current status of trial NCT00091988?
This trial is currently completed. It is a NA study. The enrollment target is 338 participants. The study started on 2004-07. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00091988?
The interventions under investigation include: Lifestyle & Behavioral Change Program (BEHAVIORAL), Structured Education Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT00091988?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00091988's enrollment target sits among peer trials
338 305th of 2000 higher than 1,696 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03253263 · 338 participants · Phase 2
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
- NCT05658731 · 338 participants · NA
Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients
- NCT06022939 · 338 participants · Phase 3
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
- NCT04176172 · 340 participants · Phase 3
Optimizing Tobacco Use Treatment for PLWHA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia